IP Library Granted Patent US 11,832,601
Granted Patent B2
US 11,832,601 · App. 16/307,982 · Granted Dec 5, 2023

Cytoplasmic incompatibility factors and methods for controlling anthropods

Inventors: Jason Metcalf (Dexter, MI); Seth R. Bordenstein (Nashville, TN); Daniel Lepage (Centertown, MO); Sarah Bordenstein (Nashville, TN); Mark Hochstrasser (Hamden, CT); John F. Beckmann (New Haven, CT); Judith Ronau (Hamden, CT)
Assignees: VANDERBILT UNIVERSITY; YALE UNIVERSITY
A01K67/0337A01K67/0339C07K14/195C12N1/205C12N9/22C12N9/6472C12N15/87A01K2217/052A01K2217/206A01K2227/706A01K2267/02C07K2319/21C12R2001/01
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,832,601
App. No.
16/307,982
Granted
Dec 5, 2023
Kind
B2
Abstract

The disclosure relates to genetically modified bacteria, genetically modified arthropods, and methods for controlling and/or reducing arthropod populations.

Claims (27)

1. A genetically modified arthropod, said arthropod comprising:

(i) a bacterial operon or two independent chromosomal insertions encoding at least two cytoplasmic incompatibility factors, wherein the bacterial operon or the two independent chromosomal insertions is from Wolbachia;

wherein the bacterial operon or the two independent chromosomal insertions encode: the cytoplasmic incompatibility factors WD0631 and WD0632; and

wherein WD0631 is encoded by SEQ ID NO: 25; and

(ii) a promoter operably linked to the bacterial operon or the two independent chromosomal insertions;

wherein the expression of the cytoplasmic incompatibility factors in a male arthropod causes a reduction in viable offspring in comparison to a male arthropod lacking the cytoplasmic incompatibility factors.

2. A genetically modified arthropod, said arthropod comprising:

(i) a bacterial operon or two independent chromosomal insertions encoding at least two cytoplasmic incompatibility factors, wherein the bacterial operon or the two independent chromosomal insertions is from Wolbachia;

wherein the bacterial operon or the two independent chromosomal insertions encode:

the cytoplasmic incompatibility factors WD0631 and WD0632; and

wherein WD0632 is encoded by SEQ ID NO: 26; and

(ii) a promoter operably linked to the bacterial operon or the two independent chromosomal insertions;

wherein the expression of the cytoplasmic incompatibility factors in a male arthropod causes a reduction in viable offspring in comparison to a male arthropod lacking the cytoplasmic incompatibility factors.

3. A genetically modified arthropod, said arthropod comprising:

(i) a bacterial operon or two independent chromosomal insertions encoding at least two cytoplasmic incompatibility factors, wherein the bacterial operon or the (wo independent chromosomal insertions is from Wolbachia;

wherein the bacterial operon or the two independent chromosomal insertions encode:

the cytoplasmic incompatibility factors CidA wPip and CidB wPip ; and

wherein CidA wPip is encoded by SEQ ID NO: 27; and

(ii) a promoter operably linked to the bacterial operon or the two independent chromosomal insertions;

wherein the expression of the cytoplasmic incompatibility factors in a male arthropod causes a reduction in viable offspring in comparison to a male arthropod Jacking the cytoplasmic incompatibility factors.

4. A genetically modified arthropod, said arthropod comprising:

(i) a bacterial operon or two independent chromosomal insertions encoding at least two cytoplasmic incompatibility factors, wherein the bacterial operon or the two independent chromosomal insertions is from Wolbachia;

wherein the bacterial operon or the two independent chromosomal insertions encode:

the cytoplasmic incompatibility factors CidA wPip and CidB wPip ; and

wherein CidB wPip is encoded by SEQ ID NO: 28; and

(ii) a promoter operably linked to the bacterial operon or the two independent chromosomal insertions:

wherein the expression of the cytoplasmic incompatibility factors in a male arthropod causes a reduction in viable offspring in comparison to a male arthropod lacking the cytoplasmic incompatibility factors.

Assignments (3)
CONFIRMATORY LICENSE Recorded Dec 11, 2020
From: VANDERBILT UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 054706/0500 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2018
From: METCALF, JASON; BORDENSTEIN, SETH R.; LEPAGE, DANIEL; BORDENSTEIN, SARAH
To: VANDERBILT UNIVERSITY
Reel/Frame 047801/0397 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 18, 2018
From: HOCHSTRASSER, MARK; RONAU, JUDITH; BECKMANN, JOHN F.
To: YALE UNIVERSITY
Reel/Frame 047801/0408 →
Continuity (2)
Provisional Application 62347818 · Jun 9, 2016
Related Publication 20190216064A1 · Jul 18, 2019